Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Clinical Trials in Portland, Oregon

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia